The local immune response to mycobacteria is complex, but mycobacterial ant
igen presentation by phagocytes to T helper cells is the pivotal interactio
n. Bacille Calmette-Guerin (BCG) vaccination is associated with the develop
ment of antituberculosis immunity but not necessarily with antitumor immuni
ty. Animal studies have shown that an intact host immune system is required
for the antitumor activity of BCG. Immunosuppressed and, particularly, T c
ell-depleted individuals fail to respond to BCG immunotherapy. Clinical and
laboratory evidence suggest that the antitumor activity is concentrated at
the site of BCG administration, which reinforces the view that local immun
e mechanisms are responsible for this phenomenon.